These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 30666755

  • 21. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
    Shimizu Y, Takamori A, Utsunomiya A, Kurimura M, Yamano Y, Hishizawa M, Hasegawa A, Kondo F, Kurihara K, Harashima N, Watanabe T, Okamura J, Masuda T, Kannagi M.
    Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
    [Abstract] [Full Text] [Related]

  • 22. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H, Ngato T, Sato K, Aoki N, Kimura S, Tanaka Y, Aizawa H, Tateno M, Celis E.
    Clin Cancer Res; 2006 Jun 15; 12(12):3814-22. PubMed ID: 16778109
    [Abstract] [Full Text] [Related]

  • 23. [Tax-targeted DC vaccine for ATL].
    Suehiro Y.
    Nihon Rinsho; 2017 Feb 15; 75(2):295-300. PubMed ID: 30562867
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tumor immunity against adult T-cell leukemia.
    Kannagi M, Harashima N, Kurihara K, Ohashi T, Utsunomiya A, Tanosaki R, Masuda M, Tomonaga M, Okamura J.
    Cancer Sci; 2005 May 15; 96(5):249-55. PubMed ID: 15904464
    [Abstract] [Full Text] [Related]

  • 31. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
    Kitazono T, Okazaki T, Araya N, Yamano Y, Yamada Y, Nakamura T, Tanaka Y, Inoue M, Ozaki S.
    Cell Immunol; 2011 May 15; 272(1):11-7. PubMed ID: 22030472
    [Abstract] [Full Text] [Related]

  • 32. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
    Sugata K, Yasunaga J, Mitobe Y, Miura M, Miyazato P, Kohara M, Matsuoka M.
    Blood; 2015 Aug 27; 126(9):1095-105. PubMed ID: 26063164
    [Abstract] [Full Text] [Related]

  • 33. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T.
    Yakugaku Zasshi; 2011 Aug 27; 131(7):1061-72. PubMed ID: 21720136
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.
    Suzuki S, Masaki A, Ishida T, Ito A, Mori F, Sato F, Narita T, Ri M, Kusumoto S, Komatsu H, Fukumori Y, Nishikawa H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R.
    Cancer Sci; 2012 Oct 27; 103(10):1764-73. PubMed ID: 22735080
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia.
    Kawamura K, Tanaka Y, Nakasone H, Ishihara Y, Kako S, Kobayashi S, Tanaka Y, Ohmori T, Uchimaru K, Okamoto S, Mineno J, Shiku H, Nishimura S, Kanda Y.
    Biol Blood Marrow Transplant; 2020 Aug 27; 26(8):1377-1385. PubMed ID: 32311478
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.